PolyTherics Purchases Warwick Effect Polymers to Expand BioPharmaceutical Offering
PolyTherics, a UK-based biotech company that develops peptide and protein-based drugs, has announced the acquisition of Warwick Effect Polymers (WEP), the developer of Speciaity Polymers and Biopolymers.